Talazoparib in patients with advanced breast cancer and a germline BRCA mutation

1. Litton, J.K.
2. Rugo, H.S.
3. Ettl, J.
4. Hurvitz, S.A.
5. Gonçalves, A.
6. Lee, K.-H.
7. Fehrenbacher, L.
8. Yerushalmi, R.
9. Mina, L.A.
10. Martin, M.
11. Roché, H.
12. Im, Y.-H.
13. Quek, R.G.W.
14. Markova, D.
15. Tudor, I.C.
16. Hannah, A.L.
17. Eiermann, W.
18. Blum, J.L.

Export

Export

×

MLA

modern-language-association

APA

apa

Chicago

chicago-fullnote-bibliography

Harvard

harvard-cite-them-right

Vancouver

vancouver-author-date

---

RIS BibTex

Export

×

This document cannot be exported because it belongs to another portal.

Full text

lock_openFull text externo

DOI: 10.1056/NEJMOA1802905 GOOGLE SCHOLAR lock_openOpen access editor

Sustainable development goals

• 

Data source: Scopus